Direktorat Registrasi ObatValid

COSOPT

Claim this product
BPOM Number
DKI2367601946A1
Approved
26 August 2025
Expiry
24 August 2030
Form
TETES MATA

About This Registration

COSOPT is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2367601946A1. Its current registration status is Valid, with the licence valid until 24 August 2030. The product is registered to MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
BOX, 3 POUCH @ 20 SINGLE DOSE CONTAINER @ 0,2 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

  • MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA

    KAB. PASURUAN

    NPWP: 12345678910

    owner
    View profile →

Manufacturing Sites

Ingredients (5)

DORZOLAMIDE HYDROCHLORIDE<DORZOLAMIDE HYDROCHLORIDE&LTBR>BR&GTTIMOLOL MALEATE

Market Intelligence

Owner Portfolio
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA holds 74 BPOM registrations
Manufacturer Scale
MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA produces 74 registered products
Registration Age
Registered for 1 year, 1 month

FDA Cross-Reference

via openFDA
Generic Name
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
OPHTHALMIC

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from MEIJI INDONESIAN PHARMACEUTICAL INDUSTRIES - INDONESIA

KANAMYCIN MEIJI

-DKL7815300144C1
Valid
Approved: Aug 3, 2026SERBUK INJEKSI
View product →

CALLISTER

-DKI2462600217A1
Valid
Approved: Dec 4, 2025TABLET SALUT SELAPUT
View product →

MEIACT 200

-DKI0665600217A1
Valid
Approved: Oct 9, 2025TABLET SALUT SELAPUT
View product →

SP TROCHES MEIJI RASA MINT

-DBL2215305712A1
Valid
Approved: Sep 29, 2025TABLET HISAP
View product →

AMPICILLIN SODIUM/SULBACTAM SODIUM

-GKL2115305544A1
Valid
Approved: Sep 25, 2025SERBUK INJEKSI
View product →

Products in the same class

XYLOCAINE

-DKI2137200384A1
Valid
Approved: Apr 10, 2026SPRAY TOPIKAL
MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA
View product →

EPIVEN

-DKL0533514701A1
Valid
Approved: Sep 12, 2025KAPSUL
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

SODIUM BICARBONATE

-GBL9518900710A1
Valid
Approved: Sep 12, 2025TABLET
PIM PHARMACEUTICALS
View product →

NOVELLHES

-DKL1733539549A1
Valid
Approved: Sep 10, 2025INFUS
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

KOMIX EXPECTORANT JAHE

-DTL1802813637A1
Valid
Approved: May 27, 2025SIRUP
BINTANG TOEDJOE
View product →
1